Postoperative Cardiac Ischemic Complications in Lung Cancer Patients

Background. Perioperative myocardial ischemia often complicates extracardiac surgery. The problems of its prediction, diagnostics, treatment and prevention are not solved. Frequency, structure and clinical features of cardiac ischemic complications of surgical treatment of lung cancer are not well understood.
The aim of the study was to investigate the frequency of postoperative myocardial infarction and myocardial ischemia in the surgical treatment of patients with non-small cell lung cancer.
Methods. The frequency (%) of myocardial infarction (MI) with and without ST segment elevation of electrocardiogram, acute myocardial ischemia in a complete sample of cancer patients (n = 2051) who underwent treatment for non-small cell lung cancer for the last 10 years was calculated. By comparing the relative indicators and calculating the Odds Ratio (OR), we studied the relationship between the cardiac ischemic events with age, type of surgery, prevalence and localization of the tumour. The clinical manifestations and pathomorphology of postoperative myocardial infarction were analysed.
Results. Cardiac ischemic complications of thoracotomy for lung cancer occurred in 2.73 % (95% CI 1.98–3.48) cases. Myocardial infarction with ST segment elevation was recorded in 1.07 % (95% CI 0.58–1.57) patients, MI without ST segment elevation – in 0.54 % (95% CI 0.17–0.9), myocardial ischemia – in 1.12 % (95% CI 0.62–1.63). An increase in the frequency of ischemic events after pneumonectomy was observed compared with lobectomy (OR 6.5, 95% CI 3.5–12.2) and after right-sided pneumonectomy compared with left-sided one (OR 3.2, 95% CI 1.6–6.3), and also the age over 70. Hospital mortality from MI was 39.3 %. According to autopsies of patients who died of МI, coronary atherothrombosis was detected in 2 of 22 cases.
Conclusion. In the surgical treatment of non-small cell lung cancer, cardiac ischemic events develop in 2.73 % of patients. The greatest risk is associated with right-sided pneumonectomy.

1. Glance LG, Lustik SJ, Hannan EL, Osler TM, Mukamel DB, Qian F, et al. The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012; 255: 696-702. doi: 10.1097/SLA.0b013e-31824b45af

2. Smilowitz NR, Gupta N, Guo Y, Berger JS, Bangalore S. Perioperative acute myocardial infarction associated with non-cardiac surgery. Eur Heart J. 2017; 38(31): 2409-2417. doi: 10.1093/eurheartj/ehx313

3. Yano T, Yokoyama H, Fukuyama Y, Takai E, Mizutani K, Ichinose Y. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg. 1997; 11(3): 445-449. doi: 10.1016/s1010-7940(96)01097-4

4. Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013; 217(5): 833-842. doi: 10.1016/j.jamcollsurg.2013.07.385

5. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg. 2001; 72(4): 1149-1154. doi: 10.1016/s0003-4975(01)02995-2

6. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. The Joint Task Force on non-cardiac surgery vascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014; 35(35): 2383-2431. doi: 10.1093/eurheartj/ehu282

7. Brunelli A, Cassivi SD, Fibla J, Halgren LA, Wigle DA, Allen MS, et al. External validation of the recalibrated thoracic revised cardiac risk index for predicting the risk of major cardiac complications after lung resection. Ann Thorac Surg. 2011; 92(2): 445-448. doi: 10.1016/j.athoracsur.2011.03.095

8. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH, et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005; 173(6): 627-634. doi: 10.1503/cmaj.050011

9. Yang CJ, Shah SA, Lin BK, Van Dusen KW, Chan DY, Tan WD, et al. Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2019; 107(4): 1074-1081. doi: 10.1016/j.athoracsur.2018.10.009

10. Smilowitz NR, Gupta N, Ramakrishna H, Guo Y, Berger JS, Bangalore S. Trends in Perioperative Major Adverse Cardiovascular and Cerebrovascular Events associated with Non-Cardiac Surgery. JAMA Cardiol. 2017; 2(2): 181-187. doi: 10.1001/jamacardio.2016.4792

11. Pricopi C, Mordant P, Rivera C, Arame A, Foucault C, Dujon A, et al. Postoperative morbidity and mortality after pneumonectomy: a 30-year experience of 2064 consecutive patients. Interact Cardiovasc Thorac Surg. 2015; 20(3): 316-321. doi: 10.1093/icvts/ivu417

12. Ferguson MK, Saha-Chaudhuri P, Mitchell JD, Varela G, Brunelli A. Prediction of major cardiovascular events after lung resection using a modified scoring system. Ann Thorac Surg. 2014; 97(4): 1135-1140. doi: 10.1016/j.athoracsur.2013.12.032

13. Rodríguez M, Gómez MT, Jiménez MF, Aranda JL, Novoa N, Varela G. The risk of death due to cardiorespiratory causes increases with time after right pneumonectomy: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2013; 44(1): 93-97. doi: 10.1093/ejcts/ezs620

14. Davydov MI, Akchurin RS, Gerasimov SS, Brand YaB, Dolgov IM. The surgical treatment of patients with lung cancer with severe concomitant cardiovascular diseases. Pirogov Rus J Surg. 2012; (7): 18-26 (In Russ.).

15. Gaissert HA, Keum DY, Wright CD, Ancukiewicz M, Monroe E, Donahue DM, et al. POINT: Operative risk of pneumonectomy - influence of preoperative induction therapy. J Thorac Cardiovasc Surg. 2009; 138(2): 289-94. doi: 10.1016/j.jtcvs.2008.11.069

16. Petrova GV, Starinsky VV, Gretsova OP, Shakhzadova AO, Samsonov Yu.V. The state of oncological assistance to the population of Russia in 2017 according to the data of federal statistical observation. P.A. Herzen Journal of Oncology. 2019; 8(1): 32-40. doi: 10.17116/onkolog2019801132 (In Russ.)

17. Puelacher C, Lurati-Buse G, Singeisen H, Dang M, Cuculi F, Müller C. Perioperative myocardial infarction/injury after noncardiac surgery. Swiss Med Wkly. 2015; 145: w14219. doi: 10.4414/smw.2015.14219

18. von Knorring J, Lepäntalo M, Lindgren L, Lindfors O. Cardiac arrhythmias and myocardial ischemia after thoracotomy for lung cancer. Ann Thorac Surg. 1992; 53(4): 642-647. doi 10.1016/0003-4975(92)90325-x

19. Frolovicheva IS, Poltavskaya MG, Syrkin AL. Comparative clinical and pathological study of perioperative and ordinary fatal myocardial infarction. Cardiology and Cardiovascular Surgery. 2016; (5): 23-28. doi: 10.17116/kardio20169523-28 (In Russ.)

20. Ploeg AJ, Kappetein AP, van Tongeren RB, Pahlplatz PV, Kastelein GW, Breslau PJ. Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung. Eur J Cardiothorac Surg. 2003; 23(1): 26-29. doi: 10.1016/s1010-7940(02)00655-3

21. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019; 40(3): 237-269. doi: 10.1093/eurheartj/ehy462

22. Zaratyants OV, Mishnev OD, Kaktursky LV. Myocardial infarction and acute coronary syndrome: definitions, classification and diagnostic criteria. Archives of Pathology. 2014; (6): 3-11. doi: 10.17116/patol20147663-11 (In Russ.)

23. Frank GA, Zayratyants OV, Shpektor AV, Kaktursky LV, Mishnev OD, Rybakova MG, et al. The formulation of the pathoanatomical diagnosis in ischemic heart disease (class IX “Circulatory system diseases” ICD-10). Clinical recommendations. Moscow; 2015. (In Russ.)

24. Kotvitskaya ZT, Kolotova GB, Rudnov VA, Bagin VA. Intraoperative risk factors for myocardial infarction in non-cardiac surgery. Messenger of anesthesiology and resuscitation. 2018; 15(2): 32-37. doi: 10.21292/2078-5658-2018-15-2-32-37 (In Russ.)

25. Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, et al. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. JAMA. 2017; 317(16): 1642-1651. doi: 10.1001/jama.2017.4360

26. Ollila A, Vikatmaa L, Virolainen J, Vikatmaa P, Leppäniemi A, Albäck A, et al. Perioperative Myocardial Infarction in Non-Cardiac Surgery Patients: A Prospective Observational Study. Scand J Surg. 2017; 106(2): 180-186. doi: 10.1177/1457496916673585

27. Glance LG, Lustik SJ, Hannan EL, Osler TM, Mukamel DB, Qian F, et al. The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery. Ann Surg. 2012; 255: 696-702. doi: 10.1097/SLA.0b013e-31824b45af

28. Yano T, Yokoyama H, Fukuyama Y, Takai E, Mizutani K, Ichinose Y. The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis. Eur J Cardiothorac Surg. 1997; 11(3): 445-449. doi: 10.1016/s1010-7940(96)01097-4

29. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg. 2001; 72(4): 1149-1154. doi: 10.1016/s0003-4975(01)02995-2

30. Brunelli A, Cassivi SD, Fibla J, Halgren LA, Wigle DA, Allen MS, et al. External validation of the recalibrated thoracic revised cardiac risk index for predicting the risk of major cardiac complications after lung resection. Ann Thorac Surg. 2011; 92(2): 445-448. doi: 10.1016/j.athoracsur.2011.03.095

31. Yang CJ, Shah SA, Lin BK, Van Dusen KW, Chan DY, Tan WD, et al. Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2019; 107(4): 1074-1081. doi: 10.1016/j.athoracsur.2018.10.009

32. Pricopi C, Mordant P, Rivera C, Arame A, Foucault C, Dujon A, et al. Postoperative morbidity and mortality after pneumonectomy: a 30-year experience of 2064 consecutive patients. Interact Cardiovasc Thorac Surg. 2015; 20(3): 316-321. doi: 10.1093/icvts/ivu417

33. Rodríguez M, Gómez MT, Jiménez MF, Aranda JL, Novoa N, Varela G. The risk of death due to cardiorespiratory causes increases with time after right pneumonectomy: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2013; 44(1): 93-97. doi: 10.1093/ejcts/ezs620

34. Gaissert HA, Keum DY, Wright CD, Ancukiewicz M, Monroe E, Donahue DM, et al. POINT: Operative risk of pneumonectomy - influence of preoperative induction therapy. J Thorac Cardiovasc Surg. 2009; 138(2): 289-94. doi: 10.1016/j.jtcvs.2008.11.069

35. Puelacher C, Lurati-Buse G, Singeisen H, Dang M, Cuculi F, Müller C. Perioperative myocardial infarction/injury after noncardiac surgery. Swiss Med Wkly. 2015; 145: w14219. doi: 10.4414/smw.2015.14219

36. Frolovicheva IS, Poltavskaya MG, Syrkin AL. Comparative clinical and pathological study of perioperative and ordinary fatal myocardial infarction. Cardiology and Cardiovascular Surgery. 2016; (5): 23-28. doi: 10.17116/kardio20169523-28 (In Russ.)